tetano
Editor, Senior Moderator
Aging Male
. 2022 Dec;25(1):202-216.
doi: 10.1080/13685538.2022.2104833.
Impact of COVID 19 on erectile function
D H Adeyemi[SUP] 1 [/SUP], A F Odetayo[SUP] 2 3 [/SUP], M A Hamed[SUP] 3 4 5 [/SUP], R E Akhigbe[SUP] 3 6 [/SUP]
Affiliations
Abstract
Purpose: COVID-19, a novel infection, presented with several complications, including socioeconomical and reproductive health challenges such as erectile dysfunction (ED). The present review summarizes the available shreds of evidence on the impact of COVID-19 on ED.Materials and methods: All published peer-reviewed articles from the onset of the COVID-19 outbreak to date, relating to ED, were reviewed. Results: Available pieces of evidence that ED is a consequence of COVID-19 are convincing. COVID-19 and ED share common risk factors such as disruption of vascular integrity, cardiovascular disease (CVD), cytokine storm, diabetes, obesity, and chronic kidney disease (CKD). COVID-19 also induces impaired pulmonary haemodynamics, increased ang II, testicular damage and low serum testosterone, and reduced arginine-dependent NO bioavailability that promotes reactive oxygen species (ROS) generation and endothelial dysfunction, resulting in ED. In addition, COVID-19 triggers psychological/mental stress and suppresses testosterone-dependent dopamine concentration, which contributes to incident ED.Conclusions: In conclusion, COVID-19 exerts a detrimental effect on male reproductive function, including erectile function. This involves a cascade of events from multiple pathways. As the pandemic dwindles, identifying the long-term effects of COVID-19-induced ED, and proffering adequate and effective measures in militating against COVID-19-induced ED remains pertinent.
Keywords: COVID-19; Coronavirus; SARS-CoV-2; endothelial dysfunction; erectile dysfunction; testosterone.
. 2022 Dec;25(1):202-216.
doi: 10.1080/13685538.2022.2104833.
Impact of COVID 19 on erectile function
D H Adeyemi[SUP] 1 [/SUP], A F Odetayo[SUP] 2 3 [/SUP], M A Hamed[SUP] 3 4 5 [/SUP], R E Akhigbe[SUP] 3 6 [/SUP]
Affiliations
- PMID: 35924485
- DOI: 10.1080/13685538.2022.2104833
Abstract
Purpose: COVID-19, a novel infection, presented with several complications, including socioeconomical and reproductive health challenges such as erectile dysfunction (ED). The present review summarizes the available shreds of evidence on the impact of COVID-19 on ED.Materials and methods: All published peer-reviewed articles from the onset of the COVID-19 outbreak to date, relating to ED, were reviewed. Results: Available pieces of evidence that ED is a consequence of COVID-19 are convincing. COVID-19 and ED share common risk factors such as disruption of vascular integrity, cardiovascular disease (CVD), cytokine storm, diabetes, obesity, and chronic kidney disease (CKD). COVID-19 also induces impaired pulmonary haemodynamics, increased ang II, testicular damage and low serum testosterone, and reduced arginine-dependent NO bioavailability that promotes reactive oxygen species (ROS) generation and endothelial dysfunction, resulting in ED. In addition, COVID-19 triggers psychological/mental stress and suppresses testosterone-dependent dopamine concentration, which contributes to incident ED.Conclusions: In conclusion, COVID-19 exerts a detrimental effect on male reproductive function, including erectile function. This involves a cascade of events from multiple pathways. As the pandemic dwindles, identifying the long-term effects of COVID-19-induced ED, and proffering adequate and effective measures in militating against COVID-19-induced ED remains pertinent.
Keywords: COVID-19; Coronavirus; SARS-CoV-2; endothelial dysfunction; erectile dysfunction; testosterone.